Effective Management of Stress Hyperglycemia in Cardiac Surgery Patients

Importance of Identifying Risk Factors for Stress Hyperglycemia

Identifying risk factors for SHG is essential for implementing preventive strategies in cardiac surgery patients. Research has shown that various factors contribute to the development of SHG, including:

1. Preoperative Conditions: Pre-existing conditions such as obesity, hypertension, and dyslipidemia are significant risk factors for SHG. Patients with a Body Mass Index (BMI) of ≥28 kg/m² have been shown to have a higher incidence of SHG following surgery (Risk Factors and Predictive Model for Stress Hyperglycemia After Cardiac Surgery in Non-Diabetic Patients).

2. Intraoperative Stressors: Procedures involving cardiopulmonary bypass (CPB) have been associated with increased insulin resistance and subsequent hyperglycemia. Factors such as blood transfusion and the use of glucocorticoids during surgery further exacerbate SHG (Risk Factors and Predictive Model for Stress Hyperglycemia After Cardiac Surgery in Non-Diabetic Patients).

3. Postoperative Stress: The postoperative period is marked by pain, inflammation, and metabolic changes that can lead to elevated blood glucose levels. Monitoring blood glucose levels in this phase is vital for timely interventions to manage SHG (Risk Factors and Predictive Model for Stress Hyperglycemia After Cardiac Surgery in Non-Diabetic Patients).

Role of Glucocorticoids in Stress Hyperglycemia Development

Glucocorticoids, commonly used in perioperative management, play a significant role in the development of SHG. These hormones increase blood glucose levels by:

• Inhibiting Insulin Secretion: Glucocorticoids can impair insulin secretion from pancreatic beta cells, leading to elevated glucose levels in the bloodstream (Risk Factors and Predictive Model for Stress Hyperglycemia After Cardiac Surgery in Non-Diabetic Patients).

• Promoting Hepatic Glucose Production: They stimulate gluconeogenesis in the liver, further contributing to hyperglycemia in stressed patients (Risk Factors and Predictive Model for Stress Hyperglycemia After Cardiac Surgery in Non-Diabetic Patients).

• Increasing Insulin Resistance: Glucocorticoids promote insulin resistance in peripheral tissues, complicating the metabolic response during and after surgery (Risk Factors and Predictive Model for Stress Hyperglycemia After Cardiac Surgery in Non-Diabetic Patients).

The careful management of glucocorticoid administration during the perioperative period is essential to mitigate SHG and its associated risks in cardiac surgery patients.

Nomogram for Predicting Stress Hyperglycemia in Non-Diabetic Patients

To enhance the prediction of SHG risk among non-diabetic cardiac surgery patients, a nomogram has been developed based on various preoperative and intraoperative factors. The nomogram integrates factors such as:

• Age
• Body Mass Index (BMI)
• Preoperative Hyperlipidemia
• Coronary Artery Bypass Grafting (CABG)
• History of Hypertension
• Blood Transfusion

This tool allows healthcare professionals to assess the likelihood of SHG in individual patients accurately. Studies indicate that utilizing this nomogram can improve early identification, enabling targeted preventive measures and individualized patient management (Risk Factors and Predictive Model for Stress Hyperglycemia After Cardiac Surgery in Non-Diabetic Patients).

Table 1: Predictive Factors for Stress Hyperglycemia

Strategies to Mitigate Hyperglycemia During Postoperative Care

Effective strategies to manage SHG in cardiac surgery patients include:

1. Continuous Glucose Monitoring: Implementing continuous glucose monitoring can help in early detection and intervention of hyperglycemia during the critical postoperative period.

2. Insulin Protocols: Utilizing insulin infusion protocols to maintain blood glucose levels within target ranges is essential. Studies suggest that maintaining blood glucose below 180 mg/dL can reduce infection rates and improve outcomes.

3. Nutritional Support: Providing adequate nutritional support, including carbohydrate management, can help stabilize blood glucose levels postoperatively. Tailored dietary plans should aim to meet caloric and nutritional needs while minimizing blood glucose spikes.

4. Medication Management: Reviewing and adjusting medications, especially glucocorticoids, during the perioperative period can significantly reduce the risk of SHG. High-risk patients may require alternative therapies to minimize hyperglycemia.

5. Patient Education: Educating patients about the importance of blood glucose monitoring and management before and after surgery can empower them and improve adherence to prescribed management plans.

FAQ Section

What is stress hyperglycemia?
Stress hyperglycemia is a temporary increase in blood glucose levels due to physiological stress, often occurring in patients undergoing surgery or experiencing major trauma or illness.

How can stress hyperglycemia affect surgical outcomes?
Stress hyperglycemia is associated with increased risk of infections, longer hospital stays, and higher mortality rates, making its management crucial for postoperative care.

What are the risk factors for developing stress hyperglycemia in cardiac surgery patients?
Risk factors include advanced age, obesity (BMI ≥ 28 kg/m²), preoperative hyperlipidemia, history of hypertension, blood transfusions, and undergoing CABG surgery.

How can stress hyperglycemia be managed in postoperative care?
Management strategies include continuous glucose monitoring, insulin protocols, nutritional support, medication management, and patient education to maintain blood glucose within target ranges.

What is a nomogram, and how does it help in predicting stress hyperglycemia?
A nomogram is a visual representation that integrates multiple risk factors to predict the likelihood of an event, such as stress hyperglycemia, allowing for individualized patient management.

References

1. Risk Factors and Predictive Model for Stress Hyperglycemia After Cardiac Surgery in Non-Diabetic Patients. Retrieved from https://doi.org/10.2147/JMDH.S515269
2. Perspectives on the current diagnostic and treatment paradigms in secondary hemophagocytic lymphohistiocytosis (HLH). Retrieved from https://doi.org/10.1186/s13023-025-03698-0
3. Molecular Genetics Solves the Conundrum of Two Brothers Affected With Proteinuria Coming With a Very Different Flavor: A Case Report. Retrieved from https://doi.org/10.1016/j.xkme.2025.100990
4. Filling the Depths: Innovative Vertical Rectus Abdominis Myocutaneous (VRAM) Flap Reconstruction in a Complex Deep Tissue Pressure Injury. Retrieved from https://doi.org/10.7759/cureus.81302
5. Nephrotic syndrome complicated with disseminated Nocardia sepsis: a case report and literature review. Retrieved from https://doi.org/10.1186/s12879-025-11018-x
6. Point-of-care ultrasound reduces the impact on departmental radiology and echocardiography services: Results of 1-year service evaluation. Retrieved from https://doi.org/10.1016/j.clinme.2025.100306